Israeli foodtech company Lavie Bio has expanded its yield-boosting seed treatment to include durum and barley as well as the original spring wheat.
Yalos (formerly known as Thrivus) is a microbiome-based treatment that boosts nutrients in the soil in which the crops are grown. It includes two natural microbes discovered in conjunction with the Evogene computational biology firm, which is Lavie’s parent company.
The Rehovot-based firm says Yalos will now be available to American and Canadian farmers growing spring wheat, durum and barley from next year, following trials in the US that had an 86 percent success rate and saw crop yields increase by 8.3 percent for durum wheat and 6.6 percent for barley.
“We are very satisfied with these results from our 2023 field trials enabling us to offer our product to durum and barley growers in 2024,” said Lavie Bio CEO Amit Noam.
“As Lavie Bio charts its course for 2024, the company remains dedicated to commercial growth by expanding to additional crops across the United States, Canada and beyond. Lavie Bio continues to lead the agricultural innovation frontier, championing sustainable practices and enhancing crop yields,” he said.
“Yalos has been impressive on our farm. As a farmer and research provider it is unusual to see a product perform as well,” said Chad Rubbelke, the owner of Rubbelke Farms in North Dakota.
Related posts

Israeli AI Safety Tool Among TIME’S Best Inventions For 2024

TAU Team Discovers Mechanism To Eliminate Cancerous Tumors

Ashdod Port Investing In Startups As Part Of Innovation Strategy

Facebook comments